Loury is a sickle cell patient and a Board Member for the Sickle Cell and Thalassaemia Support Project.
She was made aware of the new Sickle Cell treatment, Crizanlizumab, in November 2021 and asked to be put forward. In February 2022, she became one of the first people in the UK to receive it.
Since then, Loury has been receiving the treatment on a monthly basis at Birmingham City Hospital.
Find out more about Loury's experiences with the new sickle cell treatment here: